|
Volumn 32, Issue 3, 2002, Pages 27-33
|
Overseeing research on therapeutic cloning: a private ethics board responds to its critics.
a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADVANCED CELL TECHNOLOGY INC.;
ARTICLE;
BIOETHICS;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLONING;
CONFLICT OF INTEREST;
ETHICS;
FINANCIAL MANAGEMENT;
GENETICS AND REPRODUCTION;
HUMAN;
INTERPERSONAL COMMUNICATION;
MEDICAL RESEARCH;
MORALITY;
ORGANIZATION AND MANAGEMENT;
PROFESSIONAL STANDARD;
RESEARCH SUBJECT;
STANDARD;
ADVANCED CELL TECHNOLOGY INC.;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
GENETICS AND REPRODUCTION;
BIOETHICS;
BIOMEDICAL RESEARCH;
CLONING, ORGANISM;
CONFLICT OF INTEREST;
DISCLOSURE;
ETHICS COMMITTEES, RESEARCH;
FINANCIAL SUPPORT;
HUMANS;
MORALS;
PRIVATE SECTOR;
RESEARCH SUBJECTS;
|
EID: 0036580173
PISSN: 00930334
EISSN: None
Source Type: Journal
DOI: 10.2307/3528111 Document Type: Article |
Times cited : (16)
|
References (0)
|